Braidwell portfolio · 2023-09-30
Disclosed long book
$1.60 billion
Long positions
86
Calls / puts
0 / 0
Top 5 concentration
24.0%
Longs with AI data
2 / 86
Average AI 1Y
+12.7%
13F filing comparison
Quarter-over-quarter changes
2023-06-30 to 2023-09-30
Newly reported
19
No longer reported
14
Increased
32
Reduced
13
Newly reported this quarter
Present now and absent from the immediately preceding comparable filing.
| Position | Kind | Shares | Value |
|---|---|---|---|
INSULET CORP INSULET CORP | LONG | 54,500,000 | $53.6 million |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC | LONG | 44,166,000 | $49.5 million |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC | LONG | 37,509,000 | $37.3 million |
DEXCOM INC DEXCOM INC | LONG | 37,500,000 | $35.5 million |
BICYCLE THERAPEUTICS PLC BICYCLE THERAPEUTICS PLC | LONG | 1,289,872 | $25.9 million |
89BIO INC 89BIO INC | LONG | 1,590,387 | $24.6 million |
LANTHEUS HLDGS INC LANTHEUS HLDGS INC | LONG | 288,300 | $20.0 million |
INSPIRE MED SYS INC INSPIRE MED SYS INC | LONG | 100,300 | $19.9 million |
PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC | LONG | 1,109,150 | $18.5 million |
INCYTE CORP INCYTE CORP | LONG | 294,900 | $17.0 million |
TRANSMEDICS GROUP INC TRANSMEDICS GROUP INC | LONG | 307,200 | $16.8 million |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC | LONG | 15,500,000 | $15.1 million |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC | LONG | 1,348,099 | $13.0 million |
PRCT PROCEPT BIOROBOTICS CORP | LONG | 331,061 | $10.9 million |
THIRD HARMONIC BIO INC THIRD HARMONIC BIO INC | LONG | 1,653,991 | $10.6 million |
APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC | LONG | 491,113 | $10.5 million |
THE BEAUTY HEALTH COMPANY THE BEAUTY HEALTH COMPANY | LONG | 1,626,236 | $9.8 million |
AMGEN INC AMGEN INC | LONG | 36,200 | $9.7 million |
RAYZEBIO INC RAYZEBIO INC | LONG | 277,778 | $6.2 million |
No longer reported this quarter
Present in the prior comparable filing and absent from this one.
| Position | Kind | Prior shares | Prior value |
|---|---|---|---|
ACELYRIN INC ACELYRIN INC · COM | LONG | 500,000 | $10.4 million |
ACLARIS THERAPEUTICS INC ACLARIS THERAPEUTICS INC · COM | LONG | 2,901,194 | $30.1 million |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · COM NEW | LONG | 25,431 | $457,249 |
AMYRIS INC AMYRIS INC · NOTE 1.500%11/1 | LONG | 137,850,000 | $26.2 million |
BIOGEN INC BIOGEN INC · COM | LONG | 121,942 | $34.7 million |
CRINETICS PHARMACEUTICALS IN CRINETICS PHARMACEUTICALS IN · COM | LONG | 650,312 | $11.7 million |
DICE THERAPEUTICS INC DICE THERAPEUTICS INC · COM | LONG | 1,029,901 | $47.8 million |
ESPERION THERAPEUTICS INC NE ESPERION THERAPEUTICS INC NE · COM | LONG | 895,949 | $1.2 million |
ILLUMINA INC ILLUMINA INC · NOTE 8/1 | LONG | 22,645,000 | $22.6 million |
INSMED INC INSMED INC · NOTE 0.750% 6/0 | LONG | 3,500,000 | $3.0 million |
MIRATI THERAPEUTICS INC MIRATI THERAPEUTICS INC · COM | LONG | 240,625 | $8.7 million |
NUVATION BIO INC NUVATION BIO INC · COM CL A | LONG | 4,122,900 | $7.4 million |
RHYTHM PHARMACEUTICALS INC RHYTHM PHARMACEUTICALS INC · COM | LONG | 843,087 | $13.9 million |
VIR BIOTECHNOLOGY INC VIR BIOTECHNOLOGY INC · COM | LONG | 728,549 | $17.9 million |
“No longer reported” means the position is absent from this comparable 13F filing. It does not prove the manager sold it: reporting thresholds, confidential treatment, corporate actions, or instrument changes can also explain the omission.
| Position | Kind | Shares | Value | Long weight | Quarter change | AI at filing · 1Y | AI now |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INC GUARDANT HEALTH INC · NOTE 11/1 · 40131MAB5 | LONG | 268,252,000 | $185.8 million | — | UNCHANGED | — | 1Y — 5Y — |
NOVOCURE LTD NOVOCURE LTD · NOTE 11/0 · 67011XAB9 | LONG | 135,834,000 | $118.0 million | — | UNCHANGED | — | 1Y — 5Y — |
ASCENDIS PHARMA A/S ASCENDIS PHARMA A/S · NOTE 2.250% 4/0 · 04351PAD3 | LONG | 124,000,000 | $113.8 million | — | UNCHANGED | — | 1Y — 5Y — |
EXACT SCIENCES CORP EXACT SCIENCES CORP · NOTE 0.375% 3/0 · 30063PAC9 | LONG | 131,000,000 | $113.7 million | — | UNCHANGED | — | 1Y — 5Y — |
NANOSTRING TECHNOLOGIES INC NANOSTRING TECHNOLOGIES INC · NOTE 2.625% 3/0 · 63009RAD1 | LONG | 145,520,000 | $112.4 million | — | UNCHANGED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.500% 3/1 · 10806XAB8 | LONG | 114,338,000 | $109.8 million | — | REDUCED | — | 1Y — 5Y — |
NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC · COM · 64125C109 | LONG | 968,024 | $108.9 million | 6.8% | INCREASED | — | 1Y — 5Y — |
NEVRO CORP NEVRO CORP · NOTE 2.750% 4/0 · 64157FAC7 | LONG | 109,251,000 | $102.0 million | — | UNCHANGED | — | 1Y — 5Y — |
VAXCYTE INC VAXCYTE INC · COM · 92243G108 | LONG | 1,619,553 | $82.6 million | 5.2% | REDUCED | — | 1Y — 5Y — |
XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC · COM · 98420N105 | LONG | 2,103,396 | $71.9 million | 4.5% | INCREASED | — | 1Y — 5Y — |
BSX Boston Scientific | LONG | 1,164,850 | $61.5 million | 3.8% | INCREASED | — | 1Y — 5Y — |
LEGEND BIOTECH CORP LEGEND BIOTECH CORP · SPONSORED ADS · 52490G102 | LONG | 879,564 | $59.1 million | 3.7% | INCREASED | — | 1Y — 5Y — |
NUVASIVE INC NUVASIVE INC · NOTE 0.375% 3/1 · 670704AJ4 | LONG | 61,340,000 | $56.6 million | — | INCREASED | — | 1Y — 5Y — |
INSULET CORP INSULET CORP · NOTE 0.375% 9/0 · 45784PAK7 | LONG | 54,500,000 | $53.6 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
IRHYTHM HOLDINGS INC IRHYTHM HOLDINGS INC · COM · 450056106 | LONG | 568,157 | $53.6 million | 3.3% | INCREASED | — | 1Y — 5Y — |
GLAUKOS CORP GLAUKOS CORP · COM · 377322102 | LONG | 695,792 | $52.4 million | 3.3% | REDUCED | — | 1Y — 5Y — |
IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC · NOTE 4/0 · 462222AD2 | LONG | 52,740,000 | $51.8 million | — | UNCHANGED | — | 1Y — 5Y — |
BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC · NOTE 2.250% 2/0 · 10806XAD4 | LONG | 67,294,000 | $50.5 million | — | INCREASED | — | 1Y — 5Y — |
SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC · NOTE 1.250% 9/1 · 803607AD2 | LONG | 44,166,000 | $49.5 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC · NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $48.2 million | — | UNCHANGED | — | 1Y — 5Y — |
IMMUNOCORE HLDGS PLC IMMUNOCORE HLDGS PLC · ADS · 45258D105 | LONG | 906,973 | $47.1 million | — | INCREASED | — | 1Y — 5Y — |
DAY ONE BIOPHARMACEUTICALS I DAY ONE BIOPHARMACEUTICALS I · COM · 23954D109 | LONG | 3,715,573 | $45.6 million | 2.8% | INCREASED | — | 1Y — 5Y — |
NEOGENOMICS INC NEOGENOMICS INC · NOTE 0.250% 1/1 · 64049MAB6 | LONG | 62,601,000 | $45.2 million | — | INCREASED | — | 1Y — 5Y — |
NATERA INC NATERA INC · COM · 632307104 | LONG | 1,012,145 | $44.8 million | 2.8% | REDUCED | — | 1Y — 5Y — |
KEROS THERAPEUTICS INC KEROS THERAPEUTICS INC · COM · 492327101 | LONG | 1,357,309 | $43.3 million | 2.7% | INCREASED | — | 1Y — 5Y — |
ALPHATEC HLDGS INC ALPHATEC HLDGS INC · NOTE 0.750% 8/0 · 02081GAB8 | LONG | 44,750,000 | $43.1 million | — | REDUCED | — | 1Y — 5Y — |
DECIPHERA PHARMACEUTICALS IN DECIPHERA PHARMACEUTICALS IN · COM · 24344T101 | LONG | 3,336,221 | $42.4 million | 2.6% | REDUCED | — | 1Y — 5Y — |
PARAGON 28 INC PARAGON 28 INC · COM · 69913P105 | LONG | 3,361,824 | $42.2 million | 2.6% | INCREASED | — | 1Y — 5Y — |
KARYOPHARM THERAPEUTICS INC KARYOPHARM THERAPEUTICS INC · NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $40.9 million | — | UNCHANGED | — | 1Y — 5Y — |
MARAVAI LIFESCIENCES HLDGS I MARAVAI LIFESCIENCES HLDGS I · COM CL A · 56600D107 | LONG | 3,974,857 | $39.7 million | 2.5% | INCREASED | — | 1Y — 5Y — |
INSMED INC INSMED INC · NOTE 1.750% 1/1 · 457669AA7 | LONG | 39,963,000 | $39.7 million | — | UNCHANGED | — | 1Y — 5Y — |
TMO Thermo Fisher Scientific Inc. | LONG | 75,749 | $38.3 million | 2.4% | INCREASED | — | 1Y +12.3% 5Y +70.8% · 31 models |
ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM · 016255101 | LONG | 125,213 | $38.2 million | 2.4% | REDUCED | — | 1Y — 5Y — |
BIOCRYST PHARMACEUTICALS INC BIOCRYST PHARMACEUTICALS INC · COM · 09058V103 | LONG | 5,362,980 | $38.0 million | 2.4% | INCREASED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · NOTE 0.750% 6/1 · 46333XAF5 | LONG | 37,509,000 | $37.3 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
DEXCOM INC DEXCOM INC · NOTE 0.250%11/1 · 252131AK3 | LONG | 37,500,000 | $35.5 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
NEVRO CORP NEVRO CORP · COM · 64157F103 | LONG | 1,776,368 | $34.1 million | 2.1% | UNCHANGED | — | 1Y — 5Y — |
ORTHOPEDIATRICS CORP ORTHOPEDIATRICS CORP · COM · 68752L100 | LONG | 1,057,770 | $33.8 million | 2.1% | INCREASED | — | 1Y — 5Y — |
INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW · 46120E602 | LONG | 114,920 | $33.6 million | 2.1% | REDUCED | — | 1Y — 5Y — |
VIRIDIAN THERAPEUTICS INC VIRIDIAN THERAPEUTICS INC · COM · 92790C104 | LONG | 1,735,182 | $26.6 million | 1.7% | INCREASED | — | 1Y — 5Y — |
ALECTOR INC ALECTOR INC · COM · 014442107 | LONG | 4,074,120 | $26.4 million | 1.6% | REDUCED | — | 1Y — 5Y — |
NEOGENOMICS INC NEOGENOMICS INC · NOTE 1.250% 5/0 · 64049MAA8 | LONG | 28,000,000 | $26.3 million | — | UNCHANGED | — | 1Y — 5Y — |
OUTSET MED INC OUTSET MED INC · COM · 690145107 | LONG | 2,400,427 | $26.1 million | 1.6% | INCREASED | — | 1Y — 5Y — |
HARROW INC HARROW INC · COM · 415858109 | LONG | 1,808,684 | $26.0 million | 1.6% | INCREASED | — | 1Y — 5Y — |
BICYCLE THERAPEUTICS PLC BICYCLE THERAPEUTICS PLC · SPONSORED ADS · 088786108 | LONG | 1,289,872 | $25.9 million | 1.6% | NEWLY REPORTED | — | 1Y — 5Y — |
89BIO INC 89BIO INC · COM · 282559103 | LONG | 1,590,387 | $24.6 million | 1.5% | NEWLY REPORTED | — | 1Y — 5Y — |
PENUMBRA INC PENUMBRA INC · COM · 70975L107 | LONG | 95,315 | $23.1 million | 1.4% | INCREASED | — | 1Y — 5Y — |
GUARDANT HEALTH INC GUARDANT HEALTH INC · COM · 40131M109 | LONG | 689,000 | $20.4 million | 1.3% | INCREASED | — | 1Y — 5Y — |
LANTHEUS HLDGS INC LANTHEUS HLDGS INC · COM · 516544103 | LONG | 288,300 | $20.0 million | 1.3% | NEWLY REPORTED | — | 1Y — 5Y — |
CUTERA INC CUTERA INC · NOTE 2.250% 6/0 · 232109AD0 | LONG | 33,900,000 | $20.0 million | — | INCREASED | — | 1Y — 5Y — |
INSPIRE MED SYS INC INSPIRE MED SYS INC · COM · 457730109 | LONG | 100,300 | $19.9 million | 1.2% | NEWLY REPORTED | — | 1Y — 5Y — |
AXONICS INC AXONICS INC · COM · 05465P101 | LONG | 354,527 | $19.9 million | 1.2% | REDUCED | — | 1Y — 5Y — |
HILLEVAX INC HILLEVAX INC · COM · 43157M102 | LONG | 1,449,246 | $19.5 million | 1.2% | INCREASED | — | 1Y — 5Y — |
MINERALYS THERAPEUTICS INC MINERALYS THERAPEUTICS INC · COM · 603170101 | LONG | 2,023,900 | $19.2 million | 1.2% | INCREASED | — | 1Y — 5Y — |
DHR Danaher Corporation | LONG | 77,200 | $19.2 million | 1.2% | INCREASED | — | 1Y +13.2% 5Y +74.6% · 30 models |
ANAPTYSBIO INC ANAPTYSBIO INC · COM · 032724106 | LONG | 1,049,823 | $18.9 million | 1.2% | REDUCED | — | 1Y — 5Y — |
REPLIGEN CORP REPLIGEN CORP · COM · 759916109 | LONG | 118,400 | $18.8 million | 1.2% | INCREASED | — | 1Y — 5Y — |
PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC · COM · 74366E102 | LONG | 1,109,150 | $18.5 million | 1.2% | NEWLY REPORTED | — | 1Y — 5Y — |
TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC · NOTE 2.250% 3/0 · 89422GAA5 | LONG | 28,350,000 | $18.4 million | — | UNCHANGED | — | 1Y — 5Y — |
RAPT THERAPEUTICS INC RAPT THERAPEUTICS INC · COM · 75382E109 | LONG | 1,082,512 | $18.0 million | 1.1% | INCREASED | — | 1Y — 5Y — |
CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC · COM · 230031106 | LONG | 1,908,865 | $17.3 million | 1.1% | UNCHANGED | — | 1Y — 5Y — |
INCYTE CORP INCYTE CORP · COM · 45337C102 | LONG | 294,900 | $17.0 million | 1.1% | NEWLY REPORTED | — | 1Y — 5Y — |
TRANSMEDICS GROUP INC TRANSMEDICS GROUP INC · COM · 89377M109 | LONG | 307,200 | $16.8 million | 1.0% | NEWLY REPORTED | — | 1Y — 5Y — |
DBV TECHNOLOGIES S A DBV TECHNOLOGIES S A · SPONSORED ADR · 23306J101 | LONG | 12,107,785 | $16.5 million | 1.0% | UNCHANGED | — | 1Y — 5Y — |
DYNE THERAPEUTICS INC DYNE THERAPEUTICS INC · COM · 26818M108 | LONG | 1,821,972 | $16.3 million | 1.0% | INCREASED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · NOTE 1.500% 6/1 · 46333XAH1 | LONG | 15,500,000 | $15.1 million | — | NEWLY REPORTED | — | 1Y — 5Y — |
INVITAE CORP INVITAE CORP · NOTE 2.000% 9/0 · 46185LAB9 | LONG | 16,781,000 | $14.9 million | — | UNCHANGED | — | 1Y — 5Y — |
TERNS PHARMACEUTICALS INC TERNS PHARMACEUTICALS INC · COM · 880881107 | LONG | 2,840,052 | $14.3 million | 0.9% | INCREASED | — | 1Y — 5Y — |
INTEGRA LIFESCIENCES HLDGS C INTEGRA LIFESCIENCES HLDGS C · NOTE 0.500% 8/1 · 457985AM1 | LONG | 14,500,000 | $13.3 million | — | UNCHANGED | — | 1Y — 5Y — |
IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC · COM CL A · 46333X108 | LONG | 1,348,099 | $13.0 million | 0.8% | NEWLY REPORTED | — | 1Y — 5Y — |
COMPASS THERAPEUTICS INC COMPASS THERAPEUTICS INC · COM · 20454B104 | LONG | 5,954,273 | $11.7 million | 0.7% | UNCHANGED | — | 1Y — 5Y — |
ENANTA PHARMACEUTICALS INC ENANTA PHARMACEUTICALS INC · COM · 29251M106 | LONG | 1,038,310 | $11.6 million | 0.7% | UNCHANGED | — | 1Y — 5Y — |
PRCT PROCEPT BioRobotics Corp | LONG | 331,061 | $10.9 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
THIRD HARMONIC BIO INC THIRD HARMONIC BIO INC · COM · 88427A107 | LONG | 1,653,991 | $10.6 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC · COM · 03770N101 | LONG | 491,113 | $10.5 million | 0.7% | NEWLY REPORTED | — | 1Y — 5Y — |
PULMONX CORP PULMONX CORP · COM · 745848101 | LONG | 988,559 | $10.2 million | 0.6% | REDUCED | — | 1Y — 5Y — |
THE BEAUTY HEALTH COMPANY THE BEAUTY HEALTH COMPANY · COM CL A · 88331L108 | LONG | 1,626,236 | $9.8 million | 0.6% | NEWLY REPORTED | — | 1Y — 5Y — |
AMGEN INC AMGEN INC · COM · 031162100 | LONG | 36,200 | $9.7 million | 0.6% | NEWLY REPORTED | — | 1Y — 5Y — |
SEAGEN INC SEAGEN INC · COM · 81181C104 | LONG | 42,497 | $9.0 million | 0.6% | UNCHANGED | — | 1Y — 5Y — |
KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC · COM · 501147102 | LONG | 77,497 | $9.0 million | 0.6% | REDUCED | — | 1Y — 5Y — |
REPLIMUNE GROUP INC REPLIMUNE GROUP INC · COM · 76029N106 | LONG | 487,520 | $8.3 million | 0.5% | UNCHANGED | — | 1Y — 5Y — |
AGENUS INC AGENUS INC · COM NEW · 00847G705 | LONG | 6,307,030 | $7.1 million | 0.4% | INCREASED | — | 1Y — 5Y — |
RAYZEBIO INC RAYZEBIO INC · COM · 75525N107 | LONG | 277,778 | $6.2 million | 0.4% | NEWLY REPORTED | — | 1Y — 5Y — |
ALX ONCOLOGY HLDGS INC ALX ONCOLOGY HLDGS INC · COM · 00166B105 | LONG | 1,249,900 | $6.0 million | 0.4% | UNCHANGED | — | 1Y — 5Y — |
ADAPTIVE BIOTECHNOLOGIES COR ADAPTIVE BIOTECHNOLOGIES COR · COM · 00650F109 | LONG | 967,690 | $5.3 million | 0.3% | INCREASED | — | 1Y — 5Y — |
MERUS N V MERUS N V · COM · N5749R100 | LONG | 1,901,337 | $0 | 0.0% | INCREASED | — | 1Y — 5Y — |